MP10-09 DIFFERENTIAL IMPACT OF POSITIVE SURGICAL MARGIN IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA AFTER ADJUVANT AND NEOADJUVANT SYSTEMIC THERAPY: A MULTICENTER ANALYSIS.

MLA

Saitta, Cesare, et al. “Mp10-09 Differential Impact of Positive Surgical Margin in High-Risk Localized Renal Cell Carcinoma After Adjuvant and Neoadjuvant Systemic Therapy: A Multicenter Analysis.” Journal of Urology, vol. 211, May 2024, p. e141. EBSCOhost, https://doi.org/10.1097/01.JU.0001008588.39303.c9.09.

APA

Saitta, C., Meagher, M. F., Capitanio, U., Porpiglia, F., Antonelli, A., Afari, J. A., Casale, P., Tanaka, H., Nguyen, M. V., Patil, D., Hakimi, K., Cortes, J., Roberts, J., Liu, F., Mahmood, M., Matian, J., Mansour, M., Puri, D., Cerrato, C., & Yuen, K. L. (2024). Mp10-09 Differential Impact of Positive Surgical Margin in High-Risk Localized Renal Cell Carcinoma After Adjuvant and Neoadjuvant Systemic Therapy: A Multicenter Analysis. Journal of Urology, 211, e141. https://doi.org/10.1097/01.JU.0001008588.39303.c9.09

Chicago

Saitta, Cesare, Margaret F. Meagher, Umberto Capitanio, Francesco Porpiglia, Alessandro Antonelli, Jonathan A. Afari, Paolo Casale, et al. 2024. “Mp10-09 Differential Impact of Positive Surgical Margin in High-Risk Localized Renal Cell Carcinoma After Adjuvant and Neoadjuvant Systemic Therapy: A Multicenter Analysis.” Journal of Urology 211 (May): e141. doi:10.1097/01.JU.0001008588.39303.c9.09.